FANIX | FSENX | FANIX / FSENX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 30 years | 44 years | - |
Gain YTD | 8.678 | 8.628 | 101% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.12B | 1.92B | 58% |
Annual Yield % from dividends | 1.92 | 1.72 | 111% |
Returns for 1 year | 18.64 | 18.69 | 100% |
Returns for 3 years | 58.90 | 58.97 | 100% |
Returns for 5 years | 97.95 | 98.64 | 99% |
Returns for 10 years | 62.86 | 62.31 | 101% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FERIX | 48.89 | 0.64 | +1.33% |
Fidelity Advisor Emerging Asia I | |||
FGIRX | 42.36 | 0.35 | +0.83% |
Fidelity Advisor Growth & Income A | |||
JIEZX | 18.69 | 0.09 | +0.48% |
JPMorgan International Equity R2 | |||
MSBQX | 11.74 | 0.03 | +0.26% |
Morgan Stanley American Resilience R6 | |||
RCGHX | 16.49 | N/A | N/A |
Virtus KAR Health Sciences C |